Gene therapy approaches for DMD using recombinant adeno-associated viral (rAAV) vectors to deliver miniaturized (or micro) dystrophin genes to striated muscles have shown significant progress. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.